au.\*:("KRIEG, A. M")
Results 1 to 25 of 44
Selection :
An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNAKRIEG, A. M.The Journal of laboratory and clinical medicine. 1996, Vol 128, Num 2, pp 128-133, issn 0022-2143Article
CpG DNA : a pathogenic factor in systemic lupus erythematosus ?KRIEG, A. M.Journal of clinical immunology. 1995, Vol 15, Num 6, pp 284-292, issn 0271-9142Article
Toll-like receptor 9 (TLR9) agonists in the treatment of cancerKRIEG, A. M.Oncogene (Basingstoke). 2008, Vol 27, Num 2, pp 161-167, issn 0950-9232, 7 p.Article
Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifsCHEN, Y; LENERT, P; WEERATNA, R et al.Gene therapy (Basingstoke). 2001, Vol 8, Num 13, pp 1024-1032, issn 0969-7128Article
Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteriaHUANG, L.-Y; KRIEG, A. M; ELLER, N et al.Infection and immunity. 1999, Vol 67, Num 12, pp 6257-6263, issn 0019-9567Article
Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphomaWOOLDRIDGE, J. E; BALLAS, Z; KRIEG, A. M et al.Blood. 1997, Vol 89, Num 8, pp 2994-2998, issn 0006-4971Article
Endogenous retroviruses : potential etiologic agents in autoimmunityKRIEG, A. M; GOURLEY, M. F; PERL, A et al.The FASEB journal. 1992, Vol 6, Num 8, pp 2537-2544, issn 0892-6638Article
Timing of immunosuppression in the natural history of autoimmune diseasesSTEINBERG, A. D;; KRIEG, A. M; TAKASHI, T et al.Journal of autoimmunity (Print). 1992, Vol 5, pp 197-203, issn 0896-8411, SUPAConference Paper
Can immunization precipitate connective tissue disease? report of five cases of systemic lupus erythematosus and review of the literatureOLDER, S. A; BATTAFARANO, D. F; ENZENAUER, R. J et al.Seminars in arthritis and rheumatism. 1999, Vol 29, Num 3, pp 131-139, issn 0049-0172Article
Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activationZHAO, Q; SONG, X; WALDSCHMIDT, T et al.Blood. 1996, Vol 88, Num 5, pp 1788-1795, issn 0006-4971Article
Interruption of a transforming growth factor α autocrine loop in Caco-2 cells by antisense oligodeoxynucleotidesBISHOP, W. P; LIN, J; STEIN, C. A et al.Gastroenterology (New York, NY. 1943). 1995, Vol 109, Num 6, pp 1882-1889, issn 0016-5085Article
Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific mannerMOJCIK, C. F; GOURLEY, M. F; KLINMAN, D. M et al.Clinical immunology and immunopathology (Print). 1993, Vol 67, Num 2, pp 130-136, issn 0090-1229Article
Thrombotic thrombocytopenic purpura developing during pregnancy in a C2-deficient patient with a history of systemic lupus erythematosusDIXIT, R; KRIEG, A. M; ATKINSON, J. P et al.Arthritis and rheumatism. 1985, Vol 28, Num 3, pp 341-344, issn 0004-3591Article
Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production : Implications for the augmentation of Th1 responsesJAKOB, T; WALKER, P. S; KRIEG, A. M et al.International archives of allergy and immunology. 1999, Vol 118, Num 2-4, pp 457-461, issn 1018-2438Conference Paper
Molecular aspects of systemic lupus erythematosus : murine endogenous retroviral expressionGOURLEY, M. F; KISCH, W. J; MOJCIK, C. F et al.DNA and cell biology. 1992, Vol 11, Num 3, pp 253-257, issn 1044-5498Article
Preferential nuclear compartmentalization of endogenous mink cell focus-forming-related retroviral transcriptsGOURLEY, M. F; KRIEG, A. M; STEINBERG, A. D et al.The Journal of experimental medicine. 1990, Vol 171, Num 5, pp 1443-1452, issn 0022-1007, 10 p.Article
Analysis of thymic endogenous retroviral expression in murine lupus : genetic and immune studiesKRIEG, A. M; STEINBERG, A. D.The Journal of clinical investigation. 1990, Vol 86, Num 3, pp 809-816, issn 0021-9738Article
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccineCOOPER, C. L; DAVIS, H. L; CAMERON, D. W et al.Vaccine. 2004, Vol 22, Num 23-24, pp 3136-3143, issn 0264-410X, 8 p.Article
CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutansDAVIS, H. L; SUPARTO, I; HERIYANTO et al.Vaccine. 2000, Vol 18, Num 18, pp 1920-1924, issn 0264-410XArticle
Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeysJONES, T. R; OBALDIA, N. III; GRAMZINSKI, R. A et al.Vaccine. 1999, Vol 17, Num 23-24, pp 3065-3071, issn 0264-410XArticle
Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factorLIU, H.-M; NEWBROUGH, S. E; BHATIA, S. K et al.Blood. 1998, Vol 92, Num 10, pp 3730-3736, issn 0006-4971Article
Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacyKRIEG, A. M; TONKINSON, J; MATSON, S et al.Proceedings of the National Academy of Sciences of the United States of America. 1993, Vol 90, Num 3, pp 1048-1052, issn 0027-8424Article
Endogenous secretion of IL-4 maintains growth and Thy-1 expression of a transformed B cell cloneLOUIE, S. W; RAMIREZ, L. M; KRIEG, A. M et al.The Journal of immunology (1950). 1993, Vol 150, Num 2, pp 399-406, issn 0022-1767Article
Angioimmunoblastic lymphadenopathy with dysproteinemiaSTEINBERG, A. D; SELDIN, M. F; JAFFE, E. S et al.Annals of internal medicine. 1988, Vol 108, Num 4, pp 575-584, issn 0003-4819Article
Mechanism of action of CpG DNAKRIEG, A. M; HARTMANN, G; YI, A.-K et al.Current Topics in Microbiology and Immunology. 2000, Vol 247, pp 1-21, issn 0070-217XArticle